SkyWest, Inc. (NASDAQ:SKYW) will host a conference call on Wednesday, October 29, 2014, to discuss the third quarter 2014 earnings results. The format will be to provide an overview of the results followed by a Q & A session. SkyWest Inc. (NASDAQ:SKYW) in last trading activity decreased -6.08% to close at $7.88. Company weekly performance is 8.99% while its quarterly performance stands at -31.89%. SkyWest Inc. (NASDAQ:SKYW) is -53.77% away from its 52 week high. Enphase Energy Inc (NASDAQ:ENPH) said that its CFO, Kris Sennesael, will present at an upcoming investor event in Las Vegas. The company announced that the executive will be at the Roth Capital Partners Solar Symposium. That is expected to be a major solar conference in the U.S. The presentation from Enphase Energy Inc (NASDAQ:ENPH) is scheduled to take place on October 22. On last trading day Enphase Energy, Inc. (NASDAQ:ENPH) decreased -6.17% to close at $12.02. Its volatility for the week is 11.53% while volatility for the month is 8.76%. ENPH's sales growth for past 5 years was 167.50% and its EPS growth for past 5 years was -10.90%. Enphase Energy, Inc. (NASDAQ:ENPH) monthly performance is -30.72%. STR Holdings, Inc. (NYSE:STRI) will continue to be headquartered in Enfield after the Chinese firm Zhenfa takes over majority ownership. STR issued 27 million new shares of stock in order to give a 51 percent ownership stake to China-based Zhenfa Energy Group Co. for $21.7 million. STR's board told its investors the deal was the best alternative to other options that included liquidation of the entire company, and it is asking investors to approve the Zhenfa deal. On last trading day STR Holdings, Inc. (NYSE:STRI) remains unchanged to close at $1.28. Its volatility for the week is 7.17% while volatility for the month is 5.55%. STRI's sales growth for past 5 years was -35.60% and its EPS growth for past 5 years was -20.90%. STR Holdings, Inc. (NYSE:STRI) monthly performance is -11.11%. Halozyme Therapeutics, Inc. (NASDAQ:HALO) announces FDA has removed the clinical hold on patient enrollment and dosing of PEGPH20 in SWOG’s ongoing Phase 1b/2 clinical trial. Halozyme Therapeutics, Inc. (NASDAQ:HALO) in last trading activity fell -2.93% to close at $8.93. Company weekly performance is 6.18% while its quarterly performance stands at -1.65%. Halozyme Therapeutics, Inc. (NASDAQ:HALO) is -50.88% away from its 52 week high. BlackRock MuniVest Fund (NYSE:MVF) announced a monthly dividend on Monday, October 6th. Shareholders of record on Wednesday, October 15th will be paid a dividend of 0.0535 per share on Monday, November 3rd. This represents a $0.64 annualized dividend and a dividend yield of 6.60%. The ex-dividend date is Friday, October 10th. On Friday shares of BlackRock MuniVest Fund, Inc. (NYSEMKT:MVF) closed at $9.77.
Discover Hidden Gems
Don't miss the next big opportunity. Subscribe for timely alerts on potential market movers.
